Interventional Treatment of Nonculprit Lesions in Infarct‐Related Cardiogenic Shock | Journal of the American Heart Association
Approximately 70% to 80% of patients with cardiogenic shock subsequent to myocardial infarction (MI) present with multivessel disease.1 These patients display higher mortality compared with patients with single‐vessel disease.2 While percutaneous coronary intervention (PCI) of the culprit lesion is established standard practice, the optimal management of additional nonculprit lesions has only…
